Skip to content

Clinical Trial of Evidence-based Optimization Study of Acupuncture and Moxibustion Treatment for Herpes Zoster

The Construction of Evidence-based Optimization Study and Clinical Trial of Herpes Zoster based on Network-Meta

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017193
Enrollment
Unknown
Registered
2018-07-17
Start date
2018-07-30
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes Zoster

Interventions

treatment group:fire needle and cupping
control group:Valciclovir hydrochloride tablets (0.3g bid), and Vitamin B1 tablets (10mg, tid)

Sponsors

The First Afflicated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Eligible participants aged 18 to 75 years old; who suffer from herpes zoster in the recent 7 days without antiviral drugs and analgesic; whose herpes is confined to a single skin segment;who agree to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Special types of herpes zoster, including eye, ear zoster, visceral herpes zoster, meningeal herpes zoster, generalized herpes zoster and herpes zoster without rash; 2. A woman who plans to become pregnant or who are pregnant or feeding a baby; 3. who are allergy to a variety of drugs; 4. who are scar constitution; 5. who suffer from severe cardiovascular, cerebrovascular, liver, kidney, hematopoietic and other primary diseases or systemic failure, diabetes, malignant tumor, mental illness, connective tissue disease, hemophilia, haemorrhagic tendency.

Design outcomes

Primary

MeasureTime frame
effect;

Secondary

MeasureTime frame
Th17 cell;Treg cell;IL-17;IL-10;Symptom and sign quantization scale;

Countries

China

Contacts

Public ContactLIN Guohua

The First Afflicated Hospital of Guangzhou University of Traditional Chinese Medicine

tcmlin-801@163.com+86 13609021435

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026